ã°ã¬ã€ã³ã»ããªãŒ vs ããŒã«ã°ã¬ã€ã³
DCMã®æžå¿µãåæã®è³ªãç£å»åŠçã³ã³ã»ã³ãµã¹ãã«ããŒãããšããã³ã¹ããŒã¹ã®ç¡ç©ãšå šç©ã®æ¯èŒã
æçµæŽæ°: July 2026 · ããŒã¿ç¢ºèªæžã¿ FDA and WSAVA..
ã¯ã€ãã¯æ¯èŒè¡š
äžç®ã§ â ã°ã¬ã€ã³ã»ããªãŒ vs ããŒã«ã°ã¬ã€ã³:
| Dimension | ã°ã¬ã€ã³ã»ããªãŒ | ããŒã«ã°ã¬ã€ã³ |
|---|---|---|
| DCMãªã¹ã¯ | èª¿æ»æžã¿ | ç¡ |
| ã¿ã³ãã¯è³ª | 26-34% | 22-28% |
| ã³ã¹ã | $1.50-3.00 | $1.00-2.00 |
| GI | äœ | äž |
| ç ç©¶ | éå® | 50+幎 |
| ã¢ã¬ã«ã®ãŒ | <1% | æšæº |
| åæ | 泚æ | æ¢å® |
詳现åæ: ã°ã¬ã€ã³ã»ããªãŒ
äœGI
ã¡ç§ãšãžã£ã¬ã€ã¢ã¯é ãç³æŸåºã
äœã¢ã¬ã«ã®ãŒ
æ¬åœã®ã¢ã¬ã«ã®ãŒã®ã¿ïŒ<1%ïŒã
é«ã¿ã³ãã¯
2-5%å¢ãã
èæ ®äºé
- FDAãDCMãšã®é¢é£ã調æ»
- ã¡ç§/ãžã£ã¬ã€ã¢ã¯ã¿ãŠãªã³åžåé»å®³
- 99%ã®ç¬ã«ã¯äžèŠ
- AAFCOæå°åºæºãªã
- é«ã³ã¹ãã»ç¡å®èšŒã®å©ç¹
æé© 蚺æãããã¢ã¬ã«ã®ãŒã®ã¿ã
詳现åæ: ããŒã«ã°ã¬ã€ã³
ç ç©¶å®çžŸ
50幎以äžã®å®å šå®çžŸãDCMãªã¹ã¯ãªãã
å®å šãªæ é€
B矀ãç¹ç¶ãéããã°ãã·ãŠã ã
äœã³ã¹ã
AAFCOæºæ
倧æã¯ãã¹ãŠæºæ ã
é£ç©ç¹ç¶
ãªãŒãã»å€§ï¿œ|ã¯è žå 现èå¢ãæ¹åã
å¶é
- GIå€ãããé«ã
- ã¿ã³ãã¯è³ªãããäœã
æé© 99%ã«æšå¥šã
çµè«
ã»ãšãã©ã®ç¬ã«AAFCOæºæ ããŒã«ã°ã¬ã€ã³ãæšå¥šã FDAã¯ã°ã¬ã€ã³ã»ããªãŒïŒã¡ç§ãšDCMã®é¢é£ãçµ±èšçã«çºèŠã
ãããã質å
ã°ã¬ã€ã³ã»ããªãŒã¯å±éºïŒ
2018-2023幎 FDA調æ»ãé¢é£æ§ãææãWSAVAã¯æ³šæåèµ·ã
ç¬ã¯ç©ç©ãå¿ èŠïŒ
çç©åŠçã«äžèŠã ããæ é€äžã®å©ç¹ããããé«äŸ¡ãªããªãŒé£ãããã
æ é€å£«ã®æšå¥šïŒ
絊é€è©Šéšå®æœã¡ãŒã«ãŒã®AAFCOæºæ ãåªå ãããªãŒã¯ã¢ã¬ã«ã®ãŒã®ã¿ã